As shown in Figure 4A, the cisplatin resistance of glioma cells with Wnt3a stimulation was 1.67-fold higher than that of the control group, as measured by the IC50 values for cisplatin over 48 h treatment. Here, WNT3A is linked to central nervous system cancer.